Eco R1 Capital, LLC Ngm Biopharmaceuticals Inc Transaction History

Eco R1 Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.6 - $1.31 $2.43 Million - $5.31 Million	-4,049,645 Reduced 62.93%	2,385,873 $2.05 Million
Q4 2022 Feb 14, 2023	BUY	$3.41 - $12.93 $20.1 Million - $76.2 Million	5,894,410 Added 1089.32%	6,435,518 $32.3 Million
Q1 2022 May 16, 2022	BUY	$13.81 - $18.6 $5.49 Million - $7.39 Million	397,541 Added 276.9%	541,108 $8.25 Million
Q4 2020 Feb 16, 2021	BUY	$16.21 - $31.44 $2.33 Million - $4.51 Million	143,567 New	143,567 $4.35 Million
Q3 2019 Nov 14, 2019	SELL	$13.09 - $18.19 $4.15 Million - $5.76 Million	-316,900 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$12.56 - $16.6 $3.98 Million - $5.26 Million	316,900 New	316,900 $4.64 Million

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Eco R1 Capital, LLC with notifications on news.